Lemaitre Vascular (LMAT) Operating Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Operating Expenses data on file, last reported at $30.6 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $30.6 million, up 6.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $112.5 million (up 9.55% YoY), and the FY2025 annual result was $110.6 million, up 12.15% from the prior year.
• Operating Expenses climbed to $30.6 million in Q1 2026 per LMAT's latest filing, from $27.4 million in the prior quarter.
• Over five years, Operating Expenses peaked at $30.6 million in Q1 2026 and troughed at $18.0 million in Q1 2022.
• A 5-year average of $24.0 million and a median of $24.0 million in 2024 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses surged 40.7% in 2022, then advanced 2.76% in 2023.
• A 5-year view of Operating Expenses shows it stood at $19.1 million in 2022, then gained by 20.81% to $23.1 million in 2023, then grew by 11.61% to $25.7 million in 2024, then gained by 6.3% to $27.4 million in 2025, then grew by 11.93% to $30.6 million in 2026.
• Business Quant data shows LMAT's Operating Expenses at $30.6 million in Q1 2026, $27.4 million in Q4 2025, and $25.6 million in Q3 2025.